ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Defining the Mechanisms of Lymphatic Vascular Growth and Function

Active
Institution
Oklahoma Medical Research Foundation, OK
Principal investigator
Rajanarayanan S Srinivasan
Funding
$527K
Duration
2016–2026
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY/ABSTRACT Growth of lymphatic vessels from pre-existing vessels is achieved via lymphangiogenesis. The mechanisms that control lymphangiogenesis remain incompletely understood. VEGF-C binding to, and activation of, its cognate receptor VEGFR3 is the most well-studied pro-lymphangiogenic pathway known, and is necessary for the formation, migration and proliferation of lymphatic endothelial cells (LECs). Indeed, humans and mice harboring dominant negative mutations in VEGFR3 feature hypoplastic lymphatic vessels. In contrast, VEGF-C overexpression in mice results in lymphatic vessel overgrowth and dysplasia. Hence, a delicate balance of VEGF-C/VEGFR3 signaling is necessary for the proper patterning of the lymphatic vasculature. We have identified laminar shear stress (LSS) as an enhancer of VEGF-C signaling. We have also identified the G protein- coupled receptor (GPCR) sphingosine 1-phosphate (S1P) receptor 1 (S1PR1) as an antagonist of VEGF-C signaling that is enhanced by LSS. We will dissect the mechanisms by which LSS and S1PR1 regulate VEGF- C signaling. We will also investigate the significance of this mechanism during health and disease by using mouse models.

LOADING MOONBASE SCORE

NATIONAL HEART, LUNG, AND BLOOD INSTITUTER01Cardiovascular Differentiation and Development Study Section[CDD]vesselsovergrowthlymphangiogenesisreceptorlymphaticlymphatic vesselslecsmice results

Questions for Oklahoma Medical Research Foundation

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.